{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["27eeb1f5-5bce-4eff-b3b7-eef0d334ce08", "2T", 46712, "MR. MICHAEL STRATTON", 154291, "TAP PHARMACEUTICALS INC", 2008, "second_quarter", "2008-06-09T00:00:00-04:00", 5000.0, 0, 0, 1, "{\"url\": \"https://lda.senate.gov/api/v1/filings/27eeb1f5-5bce-4eff-b3b7-eef0d334ce08/\", \"filing_uuid\": \"27eeb1f5-5bce-4eff-b3b7-eef0d334ce08\", \"filing_type\": \"2T\", \"filing_type_display\": \"2nd Quarter - Termination\", \"filing_year\": 2008, \"filing_period\": \"second_quarter\", \"filing_period_display\": \"2nd Quarter (Apr 1 - June 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/27eeb1f5-5bce-4eff-b3b7-eef0d334ce08/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"5000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Michael J. Stratton\", \"dt_posted\": \"2008-06-09T00:00:00-04:00\", \"termination_date\": \"2008-06-09\", \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"6 Bald Eagle\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"Littleton\", \"registrant_state\": \"CO\", \"registrant_zip\": \"80218\", \"registrant\": {\"id\": 46712, \"url\": \"https://lda.senate.gov/api/v1/registrants/46712/\", \"house_registrant_id\": 40119, \"name\": \"MR. MICHAEL STRATTON\", \"description\": \"public relations\", \"address_1\": \"1717 Downing Street\", \"address_2\": null, \"address_3\": null, \"address_4\": null, \"city\": \"Denver\", \"state\": \"CO\", \"state_display\": \"Colorado\", \"zip\": \"80218\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"MICHAEL J. STRATTON\", \"contact_telephone\": \"+1 303-475-9070\", \"dt_updated\": \"2022-04-06T16:07:27.091860-04:00\"}, \"client\": {\"id\": 154291, \"url\": \"https://lda.senate.gov/api/v1/clients/154291/\", \"client_id\": 24, \"name\": \"TAP PHARMACEUTICALS INC\", \"general_description\": \"pharmaceuticals\", \"client_government_entity\": false, \"client_self_select\": false, \"state\": \"MD\", \"state_display\": \"Maryland\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"MD\", \"ppb_state_display\": \"Maryland\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2008-04-15\"}, \"lobbying_activities\": [{\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"Medicare Policy\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 42875, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"MICHAEL\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"STRATTON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["27eeb1f5-5bce-4eff-b3b7-eef0d334ce08"], "units": {}, "query_ms": 65.0278170069214, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}